Skip to main content
. 2014 Dec 26;17(4):363–369. doi: 10.4048/jbc.2014.17.4.363

Figure 1.

Figure 1

Comparison of cumulative incidence of cardiotoxicity events in early breast cancer between patients treated with and without trastuzumab.